Loading...
Probiotic use
Lacticin 3147 A1
Lacticin 3147 A2
Lactococcus lactis DPC 3147Lantibiotic type B
Skin infectionsbovine mastitisin-vivo (bovine model)Crispie et al.
2004
Skin infectionsbovine mastitisin-vivo (bovine model)Crispie et al.
2005
Skin infectionsbovine mastitisin-vivo (bovine model)Klostermann et al.
2010
Hospital-acquired infectionsMulti drug resistant strainin-vivo (murine model)Piper et al.
2012
Hospital-acquired infectionsMulti drug resistant strainin vitroPiper et al.
2009
Gastrointestinal tract infectionsStomach and intestine infectionsin-vitro (fermentation model)Rea et al.
2007
Urogenital tract infectionsspermicidal activityin-vivo (animal model)Silkin et al.
2008
Thuricin CDBacillus thuringiensis DPC 6431Lantibiotic type B
Gastrointestinal tract infectionsStomach and intestine infectionsin vitro / distal colon modelRea et al.
2010
Gastrointestinal tract infectionsStomach and intestine infectionsin vitro / distal colon modelRea et al.
2010
Haloduracin Hal α
Haloduracin Hal β
Bacillus haloduransLantibiotic type B
Hospital-acquired infectionsMulti drug resistant strainin-vitroOman & van der Donk
2009
PlanosporicinPlanomonospora sp. DSM14920Lantibiotic type B
Hospital-acquired infectionsMulti drug resistant strain
  • in-vitro
  • in-vivo (murine model)
Castiglione et al.
2007
Avicin AEnterococcus aviumIIa
Gastrointestinal tract infectionsStomach and intestine infectionsin-vitroBirri et al.
2010